Dehydral

Quick links to important sections

Dehydral

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dehydral

Quick Facts

Property Description
Active ingredient Methenamine (Hexamethylenetetramine)
Form Topical Solution/Liquid
Pharmacological class Antiseptic and Antiperspirant
Common use Local management of excessive perspiration
Origin Synthetic Compound

Dehydral is a specialized medicinal solution primarily classified as a topical antiseptic and an antiperspirant designed for application directly to the skin. This preparation is a synthetic, single-ingredient product utilized to manage excessive moisture and surface microbial activity. The product is clinically recognized for its efficacy in managing localized moisture issues.


What Type of Medicine is Dehydral? (Definition and Classification)

Dehydral is a liquid dermatological solution that functions as both a chemical antiperspirant and a surface antiseptic. The specific classification of Methenamine as an agent that releases formaldehyde for antimicrobial action is recognized.

The formulation is designed for topical application within a suitable aqueous or hydroalcoholic base, which facilitates drying and surface interaction. While the core constituent, Methenamine, is sometimes formulated for systemic use as a urinary tract antiseptic, this specific Dehydral preparation is manufactured exclusively for its local action on the skin, focusing entirely on surface management, such as the localized treatment necessary for individuals experiencing hyperhidrosis in specific body areas.


Methenamine: Composition and Origin (The Active Substance)

The active constituent in Dehydral is Methenamine, chemically known as Hexamethylenetetramine, a synthetic compound that is inert until activated. The composition is essential because the ingredient requires an acidic medium, such as naturally occurring sweat, to undergo hydrolysis and release the highly active molecule Formaldehyde. The key role of Formaldehyde in blocking eccrine sweat ducts is a recognized mechanism in dermatologic preparations.

The formulation is defined as a single-ingredient product, meaning its effect is derived solely from the action of Methenamine. This active substance's ability to modify tissue and microbial proteins (a process of protein denaturation) is the core feature that provides the final, therapeutic effect.


The General Purpose of This Topical Solution (Fundamental Action)

The general purpose of this topical solution is the local management of excessive perspiration and related surface microbial growth. It achieves this by creating a bactericidal action that controls the microorganisms responsible for unwanted odors, alongside its core antiperspirant function. The temporary modification achieved via protein denaturation modifies the sweat ducts, providing relief from unnecessary moisture. This mechanism establishes the solution's high-level utility: to control local moisture effectively while simultaneously utilizing the inherent antiseptic properties of its active ingredient.

What side effects are possible with Dehydral?

Possible Side Effects and Safety Information

The official safety information for this topical solution, which contains Methenamine, is primarily structured around reactions at the application site. Regulatory documents classify the possibility of adverse effects chiefly within the Skin and Subcutaneous Tissue Disorders category. These local effects are the most commonly documented.

Adverse Reaction Classifications

Category Officially Documented Reactions
Common Local skin irritation, burning sensation, stinging, and pruritus (itching).
Uncommon to Rare Dermatitis, rash, localized blistering, crusting, and potential for Allergic Contact Dermatitis.

The safety profile acknowledges that local reactions, such as stinging or irritation, may be more noticeable at the start of treatment before potentially lessening. The highest tier of serious reactions documented is Severe Allergic Contact Dermatitis or other forms of Hypersensitivity reactions, which are classified as rare in regulatory data.

Key Safety Constraints

Formal safety documents define constraints on how the solution should be used to minimize the risk of adverse events. The solution must strictly avoid contact with the eyes and mucous membranes. Furthermore, it is constrained from application on severely broken, inflamed, or injured skin to prevent unintended systemic exposure or increased local irritation. Safety profiles for the active ingredient, Methenamine, also formally note contraindications for use in patients with severe renal or hepatic impairment, based on its general pharmacological profile.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for topical Methenamine (Dehydral) is primarily structured around the risk of accidental oral ingestion of the solution, as described in government regulatory documents for the active ingredient. Overdose is classified as a risk for severe systemic toxicity if a significant amount is swallowed.


Documented Overdose Manifestations

Manifestations of systemic overdose reported in regulatory sources include severe gastrointestinal distress (nausea and vomiting) and specific effects on the urinary tract. These effects can include bladder irritation (cystitis), painful and frequent urination (dysuria), and the appearance of blood (gross hematuria) or protein (albuminuria) in the urine. Excessive topical use may result in pronounced local irritation and rash.


Officially Required Emergency Actions

Regulators mandate that individuals seek immediate medical attention or contact a poison control center following any known or suspected accidental oral ingestion. Management is defined as symptomatic and supportive treatment because no specific antidote is known. For recent, significant ingestion, officially described procedural steps include minimizing absorption via gastric lavage followed by the administration of activated charcoal. Fluids, both oral and parenteral, should be forced to tolerance as part of the supportive regimen.

Therapeutic Uses of Dehydral

What Dehydral Treats: Main Uses and Benefits

This solution is commonly used to help manage symptoms and conditions related to localized moisture and surface hygiene. As an antiperspirant preparation, it is applied when supportive symptom management is appropriate, assisting with reducing the production of perspiration at the site of application.

Primary Areas of Symptom Management

The product's therapeutic domain is relevant for managing symptoms related to excessive localized dampness (hyperhidrosis), sweat-related malodor, and the risk of skin maceration. This preparation is used to help with symptoms that may interfere with functional stability, such as persistent wetness and associated discomfort. It is applied in contexts where additional symptomatic support is needed to moderate the overall symptom load.

“The product is commonly used to help with maintaining a sense of stability when symptoms are more noticeable.”

Symptom Domains and Benefits

Quick Fact: Relief for Excessive Dampness Description
Role Assistance with symptoms of localized perspiration.
Symptom Focus Used to help with discomfort and sticky wetness.
Hygienic Benefit Contributes to a supportive deodorizing effect.
Application Context Situations requiring short-term symptomatic assistance.

The solution is applied in addressing these symptom clusters by contributing to easing the overall symptom load and may assist with maintaining functional stability of skin surfaces.

Regulatory References

  1. FDA Code of Federal Regulations on Antiperspirant Drug Products

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Dehydral — Official Regulatory Information

The eligibility profile for topical Methenamine (Dehydral) is defined by absolute contraindications and specific population restrictions outlined in official regulatory documents. Use is primarily documented for adults seeking management of localized excessive perspiration.


Contraindications and Restrictions

Classification Eligibility Rule (Regulatory Mandate)
Absolute Contraindication Individuals with a known hypersensitivity or allergy to Methenamine or its active metabolite, Formaldehyde.
Organ Impairment Prohibited for patients with severe renal insufficiency or severe hepatic insufficiency.
Application Restriction The solution must not be applied to broken, irritated, or sensitive skin, and contact with mucous membranes must be avoided.
Pediatric Use Safety and effectiveness have not been established in pediatric patients (children under 18 years of age).
Pregnancy/Lactation Use is conditional during pregnancy (often Category C) and not recommended while breastfeeding due to unknown distribution into milk.

Official regulatory documents govern eligibility by establishing clear boundaries for use based on systemic risk factors, patient history, and the absence of established safety data in certain vulnerable groups.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory information concerning the active ingredient, Methenamine, establishes specific constraints based on its chemical properties and functional requirements.

Formal Contraindications and Efficacy Constraints

Classification Interacting Agents Official Restriction and Outcome
Contraindicated Combination Sulfonamide-containing agents (e.g., Sulfamethizole) Co-administration is prohibited due to the risk of forming an insoluble precipitate with formaldehyde, the active metabolite.
Efficacy-Reducing Interaction Alkalinizing Medicinal Products (e.g., Acetazolamide, Bicarbonate-containing Antacids) These products increase pH and reduce the formation of the active formaldehyde molecule, officially leading to a loss of therapeutic efficacy.

Other Documented Interactions

Methenamine's acidic environment, which is necessary for its activation, can impact the clearance of other medicines. Regulatory information notes that co-administration may reduce the excretion of salicylates, potentially resulting in increased serum concentrations of salicylates. Furthermore, to maintain the product's functional activity, the restriction or avoidance of alkalinizing foods and beverages (such as certain dairy products and citrus juices) is officially recommended, as they interfere with the essential pH balance required for activation.

The overall interaction structure is defined by the absolute necessity to avoid specific chemical incompatibilities and to preserve the acidic environment required for the active ingredient's conversion.

Mechanism of Action

How Dihydralazine Works: Mechanism of Action

Direct Peripheral Smooth Muscle Relaxation

This mechanism describes the drug's primary action on the vascular system. Dihydralazine directly interferes with cellular calcium ( Ca^2+) homeostasis within the smooth muscle cells of the arterioles (resistance vessels). By inhibiting the processes that increase free Ca^2+—the signal required for muscle contraction—the drug causes these muscles to relax. This action initiates vasodilation, which fundamentally reduces the Peripheral Vascular Resistance (PVR).

Dynamic Engagement with the Autonomic Reflex

This domain addresses the systemic response to the drug's immediate effects. The rapid reduction in PVR and blood pressure triggers the body's intrinsic defense mechanism: the baroreceptor reflex. This compensatory mechanism involves the Autonomic Nervous System increasing the release of catecholamines, which results in the secondary physiological effect of an increased heart rate and cardiac output.

Dosage and Administration Information

The use of Dehydral, a Methenamine topical solution, is determined by its classification as a drug product for external application, requiring adherence to specific high-level administration principles. The usage protocol is characterized by a localized and intermittent application pattern.

Administration Scope Official Administration Guideline
Route of Administration The preparation is restricted to topical administration, meaning it must be applied externally directly to the skin surface.
Dosing Schedule Dosing is determined by the application, requiring a sufficient layer of solution to cover the entire localized area of concern, such as palmar or plantar surfaces. No standardized volumetric or mass-based dose is prescribed for this route.
Frequency Pattern The established use pattern is intermittent rather than continuous daily maintenance. Application occurs in short courses until the desired reduction in perspiration is attained.
Special Procedural Conditions The solution relies on interaction with a localized acidic environment at the site of application for the effective release of its active component.
Course Duration The duration of the application course is not fixed but is tied to the length of sustained symptomatic relief. Clinical observations indicate that the effect may be sustained for one to three weeks after discontinuing the short course.

Resulting Procedural Structure

Official use protocols describe the process as beginning with the topical application of the solution to only the localized site requiring treatment. The protocol defines an intermittent approach, requiring that application ceases once control is achieved. The duration of the course is thus dictated by the interval of sustained relief, after which the application may be resumed as needed.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Dehydral

The clinical evaluation of topical methenamine (the active ingredient in Dehydral) focuses on its application for localized excessive perspiration. The available information describes what types of research have been conducted, the outcomes they monitored, and the areas where further data are needed, adhering only to findings reported in authoritative scientific and regulatory sources.


Evidence for Localized Hyperhidrosis (Excessive Sweating)

The solution was studied for use in conditions characterized by fluctuating or episodic manifestations of excessive localized sweating, or hyperhidrosis. The evidence base primarily consists of controlled clinical trials, including studies designed as randomized, double-blind, and placebo-controlled trials, which are used in research examining symptom intensity or variability. These studies were observed in settings structured to compare the methenamine solution against an inactive substance (placebo) over defined time intervals. Outcomes related to physical discomfort was studied for the clinical grading of sweat production. Findings describe patterns observed in the studies over the short-term treatment period.

The available research contributes to the broader evidence landscape regarding short-term changes in localized sweating. However, the foundational evidence is derived from studies where sample sizes were modest, meaning the results apply only to the populations studied.

Durability of Effect and Follow-up Duration

Research scenarios involving temporary physiological imbalance was studied for this solution over relatively short time frames. Follow-up durations were limited, typically covering active treatment for up to four weeks (28 days). Research provides context but not individual predictions regarding how symptoms evolved in the observed populations. There is limited information for long-term outcomes, meaning long-term effects are not fully established. Research is ongoing on patterns related to continuous, extended application.

Studies in Specific Patient Groups

Research mainly involved adult patients presenting with moderate to severe essential hyperhidrosis. Comparative evidence is lacking for populations like children or older adults. Data for certain groups remain insufficient, and subgroup findings are uncertain.

Strength of Evidence and Research Limitations

The overall evidence supporting the use of methenamine topical solution has been assigned a moderate evidence level by scientific bodies. This evaluation reflects that the evidence base includes controlled trials, but evidence quality varies across studies due to factors like study age and modest scope. The certainty remains low for long-term clinical predictability. Research highlights what is known—and what is still uncertain—about this older preparation.

Frequently Asked Questions (FAQ)

Common questions about Dehydral (FAQ)


Q: Is Dehydral an over-the-counter medicine or does it need a prescription?

A: The dispensing status of Dehydral, meaning whether it requires a prescription or is available over-the-counter, can vary based on the specific country and is determined by local regulations and the product's concentration. Regulatory bodies establish the status based on the need for medical supervision.

Q: Are there any common reasons why a doctor would prescribe Dehydral?

A: Official regulatory documents state that the product is indicated for the local management of excessive perspiration, a condition medically known as hyperhidrosis. The solution is used to control excessive moisture on specific areas of the skin, such as the hands or feet.

Q: How long does the relief from Dehydral typically last?

A: Clinical observations cited in product information suggest that the antiperspirant effect may be sustained for one to three weeks after the application course is stopped. The duration of relief can vary among individuals.

Q: Is it safe to drink alcohol while I am taking Dehydral?

A: Formal regulatory warnings for a systemic interaction between topical methenamine (the active ingredient) and ingested alcohol have not been noted in the available product labeling. However, due to the alcohol content in some topical formulations, product warnings advise caution to avoid heat or open flames until the solution has completely dried on the skin.

Q: Do you have to take Dehydral with food?

A: Dehydral is a topical solution and is applied externally directly to the skin, not ingested. As a topical solution, Dehydral is applied externally and is not ingested, meaning its use is not dependent on meal times.

Q: Can Dehydral affect my sleep?

A: Official safety documents for this topical solution do not commonly list sleep-related issues as a known side effect. The adverse reactions documented in regulatory information primarily concern local skin irritation at the application site.

Q: Does Dehydral have a risk of dependence or addiction?

A: Official regulatory documents do not classify this product as having a risk of dependence or abuse. Its intended use is topical and intermittent, not systemic.

Q: Is there a maximum amount of time I should continuously use Dehydral?

A: Official product information emphasizes that the established pattern for this solution is intermittent use, not continuous daily maintenance. The product labeling states that application should be stopped once perspiration control is achieved, and it may be resumed if symptoms of excessive perspiration return.

Q: How should I store Dehydral medication?

A: In the absence of specific labeled storage instructions, consumers are advised to follow general government guidelines for managing medicines. Product warnings related to the excipients advise caution to avoid heat or open flames until the solution is completely dry, due to the presence of alcohol in some formulations.

Q: Is it normal to feel a bit dizzy after starting Dehydral?

A: Dizziness is not listed as a common or frequently reported side effect in the regulatory safety information for this topical solution. If you experience dizziness or any unexpected systemic effects, you should seek guidance from a healthcare professional.

Q: What kind of research has been done on the long-term safety of Dehydral?

A: Regulatory documents indicate that the clinical research on this solution has primarily focused on short treatment periods. Official product information notes that long-term outcomes and effects are not fully established due to the limited follow-up durations in the available studies.

Q: Why would someone be told to stop taking Dehydral suddenly?

A: The product is designed for intermittent use, meaning application should stop when perspiration is controlled. Additionally, warnings advise discontinuing use if severe skin reactions or signs of hypersensitivity (allergy) occur.

Q: Can Dehydral be crushed or cut in half?

A: As a topical solution, Dehydral is a liquid preparation. It is applied externally to the skin as a layer and is not a tablet or solid form that can be crushed or cut.

Q: Does Dehydral affect kidney function?

A: Regulatory documents state that this product is contraindicated, or prohibited, for use in patients with severe renal insufficiency (severe kidney impairment). This is an absolute restriction based on the safety profile of the active ingredient.

Q: Are there specific medical conditions that make taking Dehydral risky?

A: Official product information establishes certain absolute contraindications. These include known hypersensitivity (allergy) to the active ingredient, and conditions like severe renal insufficiency (kidney impairment) and severe hepatic insufficiency (liver impairment).

Q: What is the average duration of treatment with Dehydral?

A: The duration of the application course is not fixed; it is tied to the length of sustained symptomatic relief. According to the official protocol, application should stop once you achieve control of your excessive perspiration.

Q: Are there any common mistakes people make when using Dehydral?

A: Regulatory warnings emphasize the importance of certain precautions. These include avoiding application to broken, inflamed, or injured skin, and preventing contact with the eyes and mucous membranes.

Q: Is Dehydral safe for older adults or seniors?

A: Product information and regulatory summaries note that comparative safety and effectiveness data are limited for the older adult (geriatric) population.

Q: Can Dehydral interact with birth control pills?

A: The available regulatory documents do not include a warning for an interaction between methenamine topical solution and oral contraceptives.

Q: Does Dehydral have an expiration date I need to pay attention to?

A: All drug products legally sold are required to have an expiration date printed on the packaging or labeling. Consumers should always follow the specific date provided on the product they are using to ensure proper potency and safety.

Q: What happens if I accidentally take more Dehydral than recommended?

A: Regulatory documents include a section for overdosage information. If there is concern about the accidental ingestion or application of excessive amounts, poison control or emergency services should be contacted.

Q: Can Dehydral be taken alongside vitamin supplements?

A: Official regulatory sources do not contain any known warnings or documentation of interactions between methenamine topical solution and common vitamin supplements.

How should Dehydral be stored and disposed of?

How to Store and Dispose of Dehydral?

The official storage and disposal requirements for Dehydral are not specifically documented in publicly accessible authoritative government regulatory sources, such as the FDA Prescribing Information, EMA Summary of Product Characteristics, or TGA drug monographs. No explicit instructions regarding labeled storage temperature, protection from light or moisture, or product-specific shelf-life information are currently available from these agencies.

Official Regulatory Profile

Requirement Official Status
Labeled Storage Temperature Not Officially Specified
Protection from Light/Moisture Not Officially Specified
Product-Specific Disposal Rules Not Officially Specified

In the absence of specific, product-labeled instructions, general government guidelines for managing unused or expired medicines apply. These typically advise consumers to utilize authorized drug take-back programs when available. If a take-back program is not accessible, general government advice recommends securing the product before disposal with household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dehydral found in:

A-Z Index: